Misplaced Pages

Neuropsychopharmacology (journal)

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Peer-reviewed scientific journal Academic journal
Neuropsychopharmacology
DisciplineNeuropsychopharmacology
LanguageEnglish
Edited byTony P. George, Lisa M. Monteggia
Publication details
History1987-present
PublisherNature Portfolio
FrequencyMonthly
Open accessHybrid; delayed, after 6 months
Impact factor7.6 (2022)
Standard abbreviations
ISO 4 (alt) · Bluebook (alt)
NLM (alt) · MathSciNet (alt Paid subscription required)
ISO 4Neuropsychopharmacology
Indexing
CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt)
MIAR · NLM (alt) · Scopus
CODENNEROEW
ISSN0893-133X (print)
1740-634X (web)
OCLC no.815994337
Links

Neuropsychopharmacology is a monthly peer-reviewed scientific journal published by Nature Portfolio. It was established in 1987 and is an official publication of the American College of Neuropsychopharmacology. The journal covers all aspects of neuropsychopharmacology, including clinical and basic science research into the brain and behavior, the properties of agents acting within the central nervous system, and drug targeting and development. In addition to primary articles and reviews, the journal publishes Brainpod, a podcast highlighting content published in the journal and featuring interviews with the authorship team.

Editors-in-chief

Over the years, there have been ten editors-in-chief ("principal editors"), including J. Christian Gillin (1987-1993), Ronald D. Ciaranello (1994), Herbert Y. Meltzer (1994-1998), Hans C. Fibiger (1995-1998), Robert H. Lenox (1999-2001), Charles B. Nemeroff (2002-2006), and James H. Meador-Woodruff (2007-2012) and William A. Carlezon, Jr. (2013-2022). Since 2023, Tony P. George (University of Toronto) and Lisa M. Monteggia (Vanderbilt University) have been co-editors.

Abstracting and indexing

The journal is abstracted and indexed in:

According to the Journal Citation Reports, the journal has a 2022 impact factor of 7.6.

References

  1. "Podcasts | Neuropsychopharmacology". www.nature.com. Retrieved 2024-03-21.
  2. "About the Editors".
  3. ^ "Web of Science Master Journal List". Intellectual Property & Science. Clarivate. Retrieved 2022-06-04.
  4. "Serials cited". CAB Abstracts. CABI. Retrieved 2022-06-04.
  5. "CAS Source Index". Chemical Abstracts Service. American Chemical Society. Retrieved 2022-06-04.
  6. ^ "Neuropsychopharmacology". MIAR: Information Matrix for the Analysis of Journals. University of Barcelona. Retrieved 2022-06-04.
  7. "Embase Coverage". Embase. Elsevier. Retrieved 2022-06-04.
  8. "Neuropsychopharmacology". NLM Catalog. National Center for Biotechnology Information. Retrieved 2022-06-04.
  9. "PsycINFO Journal Coverage". American Psychological Association. Retrieved 2022-06-04.
  10. "Source details: Neuropsychopharmacology". Scopus Preview. Elsevier. Retrieved 2022-06-04.
  11. "Neuropsychopharmacology". 2022 Journal Citation Reports (Science ed.). Clarivate. 2023 – via Web of Science.

External links

Holtzbrinck Publishing Group
Holtzbrinck
DIE ZEIT Verlagsgruppe
Digital & Services
Macmillan
United
States
Trade
Macmillan Learning
Children's
United
Kingdom
Germany
Springer Nature (53%)
Categories: